Study Announcement: The Experiences of People with Chronic Lymphocytic Leukemia
CLL Society 2020 Patient Survey: MRD Testing and Limited Duration Therapy
CLL Society is asking for patient and caregiver participation in a survey which will help us learn about knowledge, attitudes, and preferences about MRD (measurable residual disease or minimal residual disease) and limited duration (also known as fixed duration) therapies. Our goal is to learn more about what our patients know and think so we can best serve you in the future. Please take a few minutes to complete this important survey.
Your survey responses will be treated in confidence and used only for statistical/research purposes. If you wish to participate, you are entitled to all rights included in the General Data Protection Regulation (GDPR), such as the right to access your information. You can withdraw your consent for any future processing of your personal information at any time by sending an email to support@cllsociety.org.
The data collected will be anonymized and combined with other people’s responses, so that identification of individual respondents will not be possible. The data will be sent directly to the nonprofit CLL Society for statistical processing.
Related posts
